Targeting inflammation to slow or delay functional decline: where are we?
Authors: Corsonello A, Garasto S, Abbatecola AM, Rose G, Passarino G, Mazzei B, Pranno L, Guffanti EE, Bustacchini S, Lattanzio F
Date: 2010
Scope of interest: biogerontology
06 99 39
Recup number
You may also be interested in:
Residual C-peptide secretion and endothelial function in type 2 diabetic patients
Authors: Manzella D, Spider E, Abbatecola AM, Grella R, Paolisso G
Date: 2003
Scope of interest: physiopathological mechanisms
Read details
Use of Plerixafor in Predicted and Proven Poor Mobilizer (according to GITMO criteria). Experience of Policlinico Universitario Tor Vergata”
Authors: Postorino M., Rossi R., Zizzari A. G., Marchesi F., Provenzano I., Franceschini L., Pupo L., Rizzo M., .Giannì L, Gumenyuk S., De Santis G., Renzi D., Guiducci G., Fiorelli E., Coniglione F., Puliti R., Berrini A., Dauri M..
Date: 2012
Scope of interest: Haematology
Read details
“Intravenous use and efficacy of ferric carboxymaltose FERINJECT in patients with iron deficiency anemia at the SIMT of Frosinone”
Authors: G. Guiducci – D.I. Gadaleta – F.Docimo – C.Gargiulo
Date: 2020
Scope of interest: CLINICAL PATHOLOGY
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
